Moderna wins second approval with vaccine targeting RSV infection – Financial Times

May 30, 2024 by quixnet

Moderna wins second approval with vaccine targeting RSV infectionFinancial Times
FDA approves Moderna’s RSV vaccine for seniors, the company’s second-ever productCNBC
FDA approves Moderna’s mRNA RSV vaccine for older adultsCNN
Moderna’s RSV shot wins FDA approval for use in older adultsThe Seattle Times
Moderna Scores FDA Approval For Its Second Product – Respiratory Syncytial Virus VaccineYahoo Finance